← Leaderboards
Stephanie L. Perry
Duke University
$504,920
Attributed
$504,920
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $152.3K · FY2007–09$200K$150K$100K$50K$0
'07
'08
'09
Funding mix
By agency
NIH$504,920 · 2
By mechanism
K23$456,712 · 1
M01$48,208 · 1
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- Thomas L Ortel$32,805,539
- Gowthami M Arepally$11,531,413
- William H Kane$4,042,669
- Alisa S Wolberg$13,659,847
- Richard Clinton Becker$11,111,515
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchCost EffectivenessCareerAccountingAcademic Medical CentersArea Under CurveAngiographyBaseBioaccumulationAnticoagulantsAdultBloodBlood VesselsCardiovascular SystemDalteparinArteriovenous FistulaClinicClinical InvestigatorDesignCoagulation ProcessComputerizedComputer SoftwareCostDialysis Procedure
Grant awards (4)
Pharmacologic Prevention of Arteriovenous Graft Thrombosis$152,215
K23 · FY2009 · HL · contact PI
Pharmacologic Prevention of Arteriovenous Graft Thrombosis$152,228
K23 · FY2008 · HL · contact PI
Pharmacologic Prevention of Arteriovenous Graft Thrombosis$152,269
K23 · FY2007 · HL · contact PI
Point of Care Monitoring of Prothrombin Time w/ APS$48,208
M01 · FY2004 · RR